|
Category:depilatory agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | red crystalline solid (est) |
| Assay: | 95.00 to 100.00
|
| Food Chemicals Codex Listed: | No |
| Soluble in: |
| | water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | depilatory agents |
| Recommendation for potassium sulfide usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for potassium sulfide flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | dipotassium monosulfide | | | dipotassium monosulfide (K2S) | | | dipotassium sulfide | | | dipotassium sulphide | | | dipotassium;sulfanide | | | potassium monosulfide | | | potassium sulfide (2:1) |
Articles:
| PubMed:Copper-catalyzed three-component synthesis of benzothiazolethiones from o-iodoanilines, isocyanide, and potassium sulfide. |
| PubMed:Copper-catalyzed double C-S bonds formation via different paths: synthesis of benzothiazoles from N-benzyl-2-iodoaniline and potassium sulfide. |
| PubMed:Cu-catalyzed double S-alkenylation of potassium sulfide: a highly efficient method for the synthesis of various thiophenes. |
| PubMed:Phosphate ions in root-tip dividing cells: a combined trapping and squash method with implications for nuclear transcription. |
| PubMed:[Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones]. |
| PubMed:[Clinico-diagnostic, therapeutic and prognostic studies of Wilson-Konovalov disease. The results of 25 years' experience]. |
| PubMed:Hepatolenticular degeneration: the comparative effectiveness of d-penicillamine, potassium sulfide, and diethylditbiocarbamate as decoppering agents. |
| PubMed:COPPER BALANCE STUDIES IN WILSON'S DISEASE; OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBACRYLAMINE RESINS, AND POTASSIUM SULFIDE. |
| PubMed:COPPER BALANCE STUDIES IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION). OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBO-RESIN AND POTASSIUM SULFIDE. |
| PubMed:[Results of the treatment of hepatolenticular degeneration with small doses of BAL, potassium sulfide and protein-rich diets]. |
| PubMed:Hepatolenticular degeneration; follow-up report of a case treated with dimercaprol (BAL), potassium sulfide, and high-protein diet. |
|
3D/inchi